Steven Hizer
Medical · Plantation, FLNPI 1154693216
Payments from drug & device makers
Across 396 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$605
- AbbVie$557
- Lilly USA, LLC$554
- GSK$519
- plus $3K from 32 others
What the payments were for
- Food & beverage$7,961100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,291 |
| Novo Nordisk | 62 | $1,078 |
| Boehringer Ingelheim | 22 | $605 |
| AbbVie | 31 | $557 |
| Lilly USA, LLC | 33 | $554 |
| GSK | 22 | $519 |
| Pfizer | 24 | $442 |
| Amgen | 27 | $368 |
| Bayer | 16 | $303 |
| Almatica Pharma LLC | 13 | $241 |
| Kowa Pharmaceuticals America, Inc. | 10 | $207 |
| Exact Sciences | 7 | $196 |
| Idorsia Pharmaceuticals US Inc | 7 | $167 |
| Antares Pharma, Inc. | 7 | $164 |
| Esperion Therapeutics, Inc. | 5 | $148 |
| Biohaven Pharmaceuticals, Inc. | 4 | $124 |
| Abbott | 7 | $123 |
| Amarin Pharma, Inc. | 8 | $115 |
| Dexcom, Inc. | 4 | $103 |
| Johnson & Johnson | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Halozyme Inc | 2 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| Novartis | 2 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $47 |
| Corcept Therapeutics | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| IBSA Pharma Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Axonics, Inc. | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
| Lucid Diagnostics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,961 in reported general payments places this provider in the 90th percentile of 2,031 medical providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 50 | $53,193 |
| OzempicSemaglutide | 30 | $46,482 |
| JardianceEmpagliflozin | 15 | $22,006 |
| EliquisApixaban | 14 | $18,384 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 14 | $15,677 |
| TrulicityDulaglutide | 11 | $10,568 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,059 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $7,586 |
| Gabapentin | 65 | $1,234 |
| Nebivolol Hcl | 12 | $1,062 |
| Atorvastatin Calcium | 113 | $1,029 |
| Ezetimibe | 36 | $524 |
| Rosuvastatin Calcium | 97 | $511 |
| Levothyroxine Sodium | 67 | $453 |
| Metoprolol Succinate | 47 | $411 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $1,291 | $53,19350 claims |
| Novo NordiskOzempic | $1,078 | $46,48230 claims |
| Boehringer IngelheimJardiance | $605 | $22,00615 claims |
| PfizerEliquis | $442 | $18,38414 claims |
| Lilly USA, LLCTrulicity | $554 | $10,56811 claims |
| GSKTrelegy Ellipta | $519 | $8,05914 claims |
| Almatica Pharma LLCSertraline Hcl | $241 | $18725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,031 medical providers in Florida.
Other medical in Plantation
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
- Francine PhillipsLand O Lakes$145K
- Chelsie FerrellDeland$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.